Weak Q1 as high start-up cost continues on first batch Biological performance supportive of strong growth ahead Expect negative changes to cons ’22e EBIT
First cycle supportive of biology and price assumptions… …while cost/kg should come down in next cycle Improvements discounted at ’24e P/E of 21x, HOLD
345 tons harvested, revenue of NOK 16m (NOK 46/kg) Operational EBIT of NOK -8m due to low scale Expects significantly lower costs in Q4 on higher volume
On track for a successful first commercial harvest of cod Upside to long-term targets, but too early to price in Downgrade to HOLD (Buy), TP up to NOK 110 (104)